← Back to Search

MOV'D + Fitbit Monitoring for Sedentary Lifestyle

N/A
Waitlist Available
Led By Marily A. Oppezzo, PhD MS, RDN, DipACLM
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Spend more than 55% of time sedentary at work
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 days at baseline, 5 days post 1-month follow-up
Awards & highlights
No Placebo-Only Group

Summary

This trial tests the MOV'D program, which sends short exercise videos and tips via social media to help people take breaks from sitting at work. It targets those who sit a lot and don't get enough exercise, aiming to improve heart health by encouraging regular exercise breaks.

Who is the study for?
This trial is for full-time employees who spend over half their work time sitting, can safely exercise (as determined by the PAR-Q), read English, and have a smartphone with internet. It's not suitable for those who don't meet these criteria.
What is being tested?
The MOV'D program aims to reduce long sitting periods at work using 'exercise snacks'—short bursts of activity—and behavior change techniques shared via social media support groups. Participants will also self-monitor with Fitbit devices.
What are the potential side effects?
Since this intervention involves moderate physical activity, potential side effects may include typical exercise-related discomforts such as muscle soreness or fatigue. However, participants are screened to ensure it's safe for them to exercise.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I spend most of my workday sitting down.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 days at baseline, 5 days post 1-month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 days at baseline, 5 days post 1-month follow-up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in average active workday hours at post-intervention
Change in average workday MVPA minutes at post-intervention
Secondary study objectives
Change in average active workday hours at follow-up
Change in average workday MVPA minutes at follow-up

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: MOV'D plus Fitbit Self-MonitoringExperimental Treatment2 Interventions
Treatment participants will be sent a Fitbit and study-provided account, and assigned to a private, study-created Twitter support group of 10 participants. Within the private group of 10, each participant is also further paired with a peer to be that person's peer coach, setting weekly exercise snack goals and practicing behavior change techniques.
Group II: Fitbit-Only Self-MonitoringActive Control1 Intervention
Control participants will be sent a Fitbit and study-provided account and will self-monitor physical activity for the duration of the study period (2 months).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Fitbit Self-Monitoring
2022
N/A
~80
MOV'D (Move Often eVery Day)
2022
N/A
~80

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments for sedentary lifestyle, such as the MOV'D intervention, work by incorporating socially-supported, evidence-based behavior change techniques and short-duration physical activity videos. These methods aim to interrupt prolonged sitting with brief bouts of moderate to vigorous physical activity, known as 'exercise snacks.' Social support through peer motivation and private social media groups enhances adherence and engagement, making it easier for individuals to integrate physical activity into their daily routines. This approach is crucial for sedentary lifestyle patients as it helps reduce the health risks associated with prolonged inactivity, such as cardiovascular disease, obesity, and metabolic syndrome, by promoting more consistent and manageable physical activity.
A systematic review of interventions to increase physical activity and reduce sedentary behaviour following bariatric surgery.Can sedentary behavior be made more active? A randomized pilot study of TV commercial stepping versus walking.

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,484 Previous Clinical Trials
17,516,049 Total Patients Enrolled
3 Trials studying Sedentary Lifestyle
635 Patients Enrolled for Sedentary Lifestyle
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,938 Previous Clinical Trials
47,792,226 Total Patients Enrolled
5 Trials studying Sedentary Lifestyle
2,473 Patients Enrolled for Sedentary Lifestyle
National Institutes of Health (NIH)NIH
2,826 Previous Clinical Trials
8,166,484 Total Patients Enrolled
1 Trials studying Sedentary Lifestyle
64 Patients Enrolled for Sedentary Lifestyle

Media Library

MOV'D (Move Often eVery Day) Clinical Trial Eligibility Overview. Trial Name: NCT05360485 — N/A
Sedentary Lifestyle Research Study Groups: Fitbit-Only Self-Monitoring, MOV'D plus Fitbit Self-Monitoring
Sedentary Lifestyle Clinical Trial 2023: MOV'D (Move Often eVery Day) Highlights & Side Effects. Trial Name: NCT05360485 — N/A
MOV'D (Move Often eVery Day) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05360485 — N/A
~20 spots leftby Dec 2025